Add to ORKGWe conclude that treatment with MMF of kidney transplant patients does not affect the proliferative rate of cells of the allograft, but decreases the number of apoptotic cells in tubular epithelium
BACKGROUND: Mycophenolate mofetil (MMF) has increasingly replaced azathioprine (AZA) as the antimeta...
The Mycophenolate Steroids Sparing (MYSS) study found that in renal transplant recipients who were o...
Background. Fixed-dose mycophenolate mofetil (MMF) reduces the incidence of acute rejection after so...
BackgroundThree large-scale clinical trials conducted in North America, Europe, and Australia showed...
OBJECTIVES: Chronic transplant dysfunction after kidney transplantation is a major reason of kid...
The impact of mycophenolate mofetil (MMF) on initial renal transplant function is not well character...
Preliminary studies suggested that mycophenolate mofetil (MMF), which inhibits proliferation of T an...
Preliminary studies suggested that mycophenolate mofetil (MMF), which inhibits proliferation of T an...
Background. The search for more effective and less toxic immunosuppressive agents to control transpl...
Background and objectives: The effect of mycophenolate mofetil (MMF) on T cell function has not been...
Background. The European double-blind, placebo (PLA) controlled study of mycophenolate mofetil (MMF)...
BACKGROUND: Both mycophenolate mofetil (MMF) and azathioprine (AZA) are immunosuppressive...
Mycophenolate mofetil attenuates renal injury in the rat remnant kidney.BackgroundMycophenolate mofe...
Background. The European double-blind, placebo (PLA) controlled study of mycophenolate mofetil (MMF)...
OVER THE last few years, new models of specific immunomodulation have been sought after in order t...
BACKGROUND: Mycophenolate mofetil (MMF) has increasingly replaced azathioprine (AZA) as the antimeta...
The Mycophenolate Steroids Sparing (MYSS) study found that in renal transplant recipients who were o...
Background. Fixed-dose mycophenolate mofetil (MMF) reduces the incidence of acute rejection after so...
BackgroundThree large-scale clinical trials conducted in North America, Europe, and Australia showed...
OBJECTIVES: Chronic transplant dysfunction after kidney transplantation is a major reason of kid...
The impact of mycophenolate mofetil (MMF) on initial renal transplant function is not well character...
Preliminary studies suggested that mycophenolate mofetil (MMF), which inhibits proliferation of T an...
Preliminary studies suggested that mycophenolate mofetil (MMF), which inhibits proliferation of T an...
Background. The search for more effective and less toxic immunosuppressive agents to control transpl...
Background and objectives: The effect of mycophenolate mofetil (MMF) on T cell function has not been...
Background. The European double-blind, placebo (PLA) controlled study of mycophenolate mofetil (MMF)...
BACKGROUND: Both mycophenolate mofetil (MMF) and azathioprine (AZA) are immunosuppressive...
Mycophenolate mofetil attenuates renal injury in the rat remnant kidney.BackgroundMycophenolate mofe...
Background. The European double-blind, placebo (PLA) controlled study of mycophenolate mofetil (MMF)...
OVER THE last few years, new models of specific immunomodulation have been sought after in order t...
BACKGROUND: Mycophenolate mofetil (MMF) has increasingly replaced azathioprine (AZA) as the antimeta...
The Mycophenolate Steroids Sparing (MYSS) study found that in renal transplant recipients who were o...
Background. Fixed-dose mycophenolate mofetil (MMF) reduces the incidence of acute rejection after so...